We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRO
351
DELISTED
Akero Therapeutics
AKRO
$81.7K ﹤0.01%
1,721
-66
-4% -$3.2K
MIRM icon
352
Mirum Pharmaceuticals
MIRM
$6.87B
$79.2K ﹤0.01%
1,081
-147
-12% -$9.35K
KRC icon
353
Kilroy Realty
KRC
$4.6B
$78.9K ﹤0.01%
1,868
-114
-6% -$4.5K
ACAD icon
354
Acadia Pharmaceuticals
ACAD
$4.55B
$77.5K ﹤0.01%
3,630
-630
-15% -$14.9K
SRRK icon
355
Scholar Rock
SRRK
$5.87B
$77K ﹤0.01%
2,068
-328
-14% -$11.5K
MAC icon
356
Macerich
MAC
$7.22B
$75.5K ﹤0.01%
4,150
-304
-7% -$5.26K
ADMA icon
357
ADMA Biologics
ADMA
$2.01B
$75.3K ﹤0.01%
5,134
-919
-15% -$15.8K
LGND icon
358
Ligand Pharmaceuticals
LGND
$5.94B
$74.8K ﹤0.01%
422
-62
-13% -$9.22K
SBRA icon
359
Sabra Healthcare REIT
SBRA
$5.38B
$74.4K ﹤0.01%
3,993
-203
-5% -$3.79K
EPR icon
360
EPR Properties
EPR
$4.9B
$73.2K ﹤0.01%
1,261
-81
-6% -$4.55K
PECO icon
361
Phillips Edison & Co
PECO
$5.45B
$71.6K ﹤0.01%
2,085
-130
-6% -$4.5K
SLG icon
362
SL Green Realty
SLG
$3.81B
$70.9K ﹤0.01%
1,185
-67
-5% -$3.97K
MRP
363
Millrose Properties Inc
MRP
$4.69B
$69.6K ﹤0.01%
2,071
-105
-5% -$3.39K
NAMS icon
364
NewAmsterdam Pharma
NAMS
$3.33B
$68.9K ﹤0.01%
2,423
+58
+2% +$1.39K
QURE icon
365
uniQure
QURE
$2.93B
$68.9K ﹤0.01%
1,180
-68
-5% -$1.24K
AMRX icon
366
Amneal Pharmaceuticals
AMRX
$5.91B
$67.6K ﹤0.01%
6,757
-1,177
-15% -$10.6K
XENE icon
367
Xenon Pharmaceuticals
XENE
$6.2B
$66.6K ﹤0.01%
1,659
-293
-15% -$10.3K
CGON icon
368
CG Oncology
CGON
$6.44B
$66.1K ﹤0.01%
1,640
-91
-5% -$2.65K
DLTR icon
369
Dollar Tree
DLTR
$24.7B
$66.1K ﹤0.01%
700
-8,322
-92% -$891K
INDV icon
370
Indivior Pharmaceuticals
INDV
$4.75B
$64.7K ﹤0.01%
2,684
-806
-23% -$16.9K
SKT icon
371
Tanger
SKT
$4.71B
$64K ﹤0.01%
1,891
-109
-5% -$3.55K
IRT icon
372
Independence Realty Trust
IRT
$3.93B
$63.1K ﹤0.01%
3,852
-213
-5% -$3.69K
RARE icon
373
Ultragenyx Pharmaceutical
RARE
$2.56B
$62.4K ﹤0.01%
2,073
-291
-12% -$8.73K
NHI icon
374
National Health Investors
NHI
$3.69B
$62.2K ﹤0.01%
782
-39
-5% -$2.92K
APLS
375
DELISTED
Apellis Pharmaceuticals
APLS
$61.5K ﹤0.01%
2,717
-468
-15% -$10.9K
13 14
15
16 17

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.